Submissions from 2025
Guselkumab for Moderate to Severe Psoriasis Across All Skin Tones: Cohort A of the VISIBLE Randomized Clinical Trial, Andrew Alexis, Amy McMichael, Jennifer Soung, Olivia Choi, Theodore Alkousakis, Javier Alonso-Llamazares, Mona Shahriari, Adrian O. Rodriguez, Tina Bhutani, Daphne Chan, Katelyn Rowland, Maxwell Sauder, H Chih-Ho Hong, Geeta Yadav, Jensen Yeung, Jenny Jeyarajah, Tony Ma, Long-Long Gao, Laura Park-Wyllie, Lawrence Green, Mark Lee, Neelam Vashi, Chesahna Kindred, Pearl Grimes, Susan C. Taylor, and Seemal R. Desai
Large Basal Cell Carcinoma Treated with Combination Topical Therapy, Kabir Al-Tariq, Rama Abdin, and Naiem T. Issa
Defining On-Treatment Remission in Plaque Psoriasis: A Consensus Statement From the National Psoriasis Foundation, April W. Armstrong, George C. Gondo, Joseph F. Merola, Alyssa M. Roberts, Lourdes M. Pérez-Chada, Deepak M. Balak, Guy S. Eakin, Charlotte Read, Stephanie T. Le, Yasmin Gutierrez, Tina Bhutani, Andrew Blauvelt, Kristina Callis Duffin, Steven Fakharzadeh, Steven R. Feldman, Joel M. Gelfand, Dafna D. Gladman, Brad Glick, Lawrence J. Green, George Han, Jason E. Hawkes, Samuel T. Hwang, Nicole Johnsen, Robert E. Kalb, Leon Kircik, Richard G. Langley, Mark G. Lebwohl, G Michael Lewitt, Emanual Maverakis, Ronald Prussick, Soumya M. Reddy, and Cheryl F. Rosen
Improving the quality of atopic dermatitis epidemiological research in the United States- A systematic review of disease definitions and related content in national surveys, Sarah L. Becker, Gina N. Bash, Wendy Smith Begolka, Tenesha Wallace-Hood, Junko Takeshita, Aaron M. Drucker, Jonathan Silverberg, Lawrence F. Eichenfield, Katrina Abuabara, Bryan Dosono, Andrew Hamilton, Robyn Okereke, and Eric Simpson
Skin Clearance, Duration of Treatment-free Interval, and Safety of Tapinarof Cream 1% Once Daily: Results from ADORING 3, a 48-week Phase 3 Open-label Extension Trial in Adults and Children Down to 2 Years of Age with Atopic Dermatitis, Robert Bissonnette, Linda Stein Gold, Leon Kircik, Eric L. Simpson, Lawrence F. Eichenfield, John Browning, Adelaide A. Hebert, Andrew F. Alexis, Weily Soong, Stephen C. Piscitelli, Anna M. Tallman, David S. Rubenstein, Philip M. Brown, and Jonathan I. Silverberg
Two for One: Tuberculid and Leukocytoclastic Vasculitis in an Adolescent, Jordan K. Bui, Mairead Baker, and Kaiane Habeshian
Systemic Corticosteroid Use in Atopic Dermatitis: A Position Paper to Inform Safer Clinical Practice and Policy, Joshua Burshtein, Christopher G. Bunick, Ruth Ann Vleugels, April W. Armstrong, Alexandra K. Golant, Todd Schlesinger, Bruce E. Strober, Eingun James Song, Linda Stein Gold, and Mark Lebwohl
A Modified Tissue-Saving Technique with Silver Nitrate to Obliterate Tunnels for Hidradenitis Suppurativa, Hannah R. Chang, Emily Murphy, Duaa Abdel Hameid, Madeline Ngo, and Melissa M. Mauskar
Long-Term Safety of Abrocitinib in Moderate-to-Severe Atopic Dermatitis: Integrated Analysis by Age, Michael J. Cork, Mette Deleuran, Bob Geng, Jonathan I. Silverberg, Eric L. Simpson, Linda F. Stein Gold, Alan D. Irvine, William Romero, Hernan Valdez, Haiyun Fan, and Justine Alderfer
Targeted dual biologic therapy for erythroderma of unknown etiology guided by high-parameter peripheral blood immunophenotyping, Hannah L. Cornman, Martin P. Alphonse, Arbor Dykema, Alexander L. Kollhoff, Kevin K. Lee, Jaya Manjunath, Emily Z. Ma, Varsha Parthasarathy, Junwen Deng, Thomas Pritchard, Anusha Kambala, Melika Marani, Kayla A. Parr, Javid P. Mohammed, Madan M. Kwatra, Jay H. Bream, Won Jin Ho, and Shawn G. Kwatra
Focused update: Guidelines of care for the management of atopic dermatitis in adults, Dawn M. Davis, Lindsy Frazer-Green, Ali Alikhan, Lionel Bercovitch, David E. Cohen, Jennifer M. Darr, Aaron M. Drucker, Lawrence F. Eichenfield, Amy S. Paller, Kathryn Schwarzenberger, Jonathan I. Silverberg, Anne Marie Singh, Peggy A. Wu, and Robert Sidbury
Use of Midodrine for Intraoperative Hemostasis in Cutaneous and Percutaneous Surgery, Joanna Dong, Naiem T. Issa, Michael Kaiser, Simonetta I. Gaumond, Michael Solis, Joel Gil, Robert S. Kirsner, Stephen C. Davis, and Joaquin J. Jimenez
Unmet Needs of Effective Advanced Systemic Therapies in Moderate-to-Severe Atopic Dermatitis Patients in the TARGET-DERM AD Registry, Dawn Z. Eichenfield, Keith D. Knapp, Ami Claxton, Breda Munoz, Julie M. Crawford, Sanjeev Balu, Yestle Kim, Shannon Schneider, Michael A. Haft, Jonathan I. Silverberg, Diamant Thaci, Lawrence F. Eichenfield, Jerry Bagel, Jamie W. Rhoads, and Amy S. Paller
Dysregulated autoantibodies targeting AGTR1 are associated with the accumulation of COVID-19 symptoms, Dennyson Leandro Fonseca, Maj Jäpel, Michael Adu Gyamfi, Igor Salerno Filgueiras, Gabriela Crispim Baiochi, Yuri Ostrinski, Gilad Halpert, Yael Bublil Lavi, Elroy Vojdani, Thayna Silva-Sousa, Júlia Nakanishi Usuda, Juan Carlo E Silva, Paula P. Freire, Adriel Leal Nóbile, Anny Silva Adri, Pedro Marçal Barcelos, Yohan Lucas Corrêa, Fernando Yuri do Vale, Letícia Oliveira Lopes, Solveig Lea Schmidt, Xiaoqing Wang, Carl Vahldieck, Benedikt Fels, Lena F. Schimke, Gustavo Cabral-Miranda, Mario Hiroyuki Hirata, Taj Ali AKhan, Yen-Rei A. Yu, Rodrigo Js Dalmolin, Howard Amital, Aristo Vojdani, and Haroldo Dutra Dias
Tapinarof cream 1% once daily was well tolerated in adults and children with atopic dermatitis in two phase 3 randomized trials, Linda Stein Gold, James Del Rosso, Benjamin D. Ehst, Matthew J. Zirwas, Lawrence J. Green, Philip M. Brown, David S. Rubenstein, Stephen C. Piscitelli, and Anna M. Tallman
Roflumilast Foam, 0.3%, for Psoriasis of the Scalp and Body: The ARRECTOR Phase 3 Randomized Clinical Trial, Melinda J. Gooderham, Javier Alonso-Llamazares, Jerry Bagel, Neal Bhatia, Michael Bukhalo, Janet DuBois, Laura K. Ferris, Lawrence Green, Leon H. Kircik, Benjamin Lockshin, Wei Jing Loo, Kim A. Papp, Jennifer Soung, Melissa S. Seal, Scott Snyder, Saori Kato, David Krupa, Patrick Burnett, David R. Berk, and David H. Chu
Long-term safety and efficacy of delgocitinib cream for up to 52 weeks in adults with Chronic Hand Eczema: results of the phase 3 open-label extension DELTA 3 trial following the DELTA 1 and 2 trials, Melinda Gooderham, Sonja Molin, Robert Bissonnette, Margitta Worm, Marie-Noëlle Crépy, Luca Stingeni, Richard B. Warren, Sibylle Schliemann, Marie-Louise Schuttelaar, Silvia Ferrucci, Esther Serra-Baldrich, Jonathan I. Silverberg, Cherry Lou Balita-Crisostomo, Marie Louise Oesterdal, Ursula Plohberger, and Tove Agner
Boosting Skin Microcirculation for Androgenetic Alopecia: Does It Work?, Ayman Grada and Naiem Issa
Brodalumab as a Second-Line Therapy in Psoriasis: Rapid Response and Unique Mechanism of Action After Biologic Failure, Lawrence Green, April Armstrong, George Han, and Abby Jacobson
Two-Year Efficacy and Safety of Lebrikizumab in Patients with Moderate-to-Severe Atopic Dermatitis: A Long-Term Extension (ADjoin), Emma Guttman-Yassky, Stephan Weidinger, Eric L. Simpson, Melinda Gooderham, Alan D. Irvine, Lynda Spelman, Jonathan I. Silverberg, Hany ElMaraghy, Louise DeLuca-Carter, Maria Lucia Piruzeli, Chaoran Hu, Fan Emily Yang, Evangeline Pierce, Laia Bardolet, and Diamant Thaçi
Burden of Pain and Use of Analgesics in Patients With Chronic Hand Eczema-Findings From the Danish Skin Cohort, Jeanette Halskou Haugaard, Johan Sieborg, Emma Guttman-Yassky, David Thein, Jonathan I. Silverberg, Lars Erik Kristensen, Jacob P. Thyssen, and Alexander Egeberg
The Heterogeneous Clinical Manifestations of Atopic Dermatitis Across Diverse Patient Populations, Joshua Horeczko, Andrew Alexis, and Jonathan I. Silverberg
The Heterogeneous Clinical Manifestations of Atopic Dermatitis Across Diverse Patient Populations, Joshua Horeczko, Andrew Alexis, and Jonathan I. Silverberg
North American Contact Dermatitis Group Patch Test Results: 2021-2022, Marie-Claude Houle, Joel G. DeKoven, Amber Reck Atwater, Margo J. Reeder, Erin M. Warshaw, Melanie D. Pratt, Donald V. Belsito, Brandon L. Adler, Jonathan Silverberg, JiaDe Yu, Nina Botto, Christen M. Mowad, Cory A. Dunnick, and James S. Taylor
Summary of Research: Comparable Efficacy and Safety of Brodalumab in Obese and Nonobese Patients with Psoriasis: Analysis of Two Randomized Controlled Trials, Sylvia Hsu, Lawrence J. Green, Mark G. Lebwohl, and Abby A. Jacobson
Summary of Research: Comparable Efficacy and Safety of Brodalumab in Obese and Nonobese Patients with Psoriasis: Analysis of Two Randomized Controlled Trials, Sylvia Hsu, Lawrence J. Green, Mark G. Lebwohl, and Abby A. Jacobson
Efficacy and Safety of Upadacitinib in Patients With Moderate-to-Severe Atopic Dermatitis: Phase 3 Randomized Clinical Trial Results Through 140 Weeks, Alan D. Irvine, Vimal H. Prajapati, Emma Guttman-Yassky, Eric L. Simpson, Kim A. Papp, Andrew Blauvelt, Chia-Yu Chu, H Chih-Ho Hong, Linda F. Gold, Marjolein de Bruin-Weller, Thomas Bieber, Kenji Kabashima, David Rosmarin, Cristina Sancho, Brian M. Calimlim, Ayman Grada, Yang Yang, Xiaoqiang Wu, Gweneth Levy, Eliza M. Raymundo, Henrique D. Teixeira, and Jonathan I. Silverberg
Recommendations to Improve Outcomes in Acne and Acne Sequelae: A Focus on Trifarotene and Other Retinoids, Naiem Issa, Andrew Alexis, Hilary Baldwin, Iltefat Hamzavi, Adelaide Hebert, Pearl Kwong, Edward Lain, Angela Moore, Omar Noor, Todd Schlesinger, Jonathan Weiss, Heather Woolery-Lloyd, J P. York, Kate Zibilich Holcomb, Leon Kircik, and Rajeev Chavda
Recommendations to Improve Outcomes in Acne and Acne Sequelae: A Focus on Trifarotene and Other Retinoids, Naiem Issa, Andrew Alexis, Hilary Baldwin, Iltefat Hamzavi, Adelaide Hebert, Pearl Kwong, Edward Lain, Angela Moore, Omar Noor, Todd Schlesinger, Jonathan Weiss, Heather Woolery-Lloyd, J P. York, Kate Zibilich Holcomb, Leon Kircik, and Rajeev Chavda
Demystifying Small-Molecule Phosphodiesterase-IV Inhibition: Computer-Aided Rational Drug Design for Future Precision Drug Development, Naiem T. Issa
Real-World Use of Tapinarof Cream 1% Once Daily in Patients with Seborrheic Dermatitis: A Case Series, Naiem T. Issa and Lidia Pomaville
Acral Lentiginous Melanoma. Part II. Staging, Surgical Management, The Role of Systemic Therapy, Shortcomings and Future Directions, Daniella Jaguan, Sach Thakker, Micah Belzberg, Nina Gulati, Janeth R. Campbell, Brittney K. DeClerck, Vishal A. Patel, and Gino K. In
A Comparison of Large Language Model Powered Search Tools Reveal Differences in Output Quality, Information Transparency, and Accessibility for Mohs Micrographic Surgery Inquiries, Neil K. Jairath, Sumanth Chennareddy, Sophia Manduca, Adriana Lopez, Murad Alam, Nicholas Golda, Elise Ng, Vishal A. Patel, Emily S. Ruiz, Joshua W. Trufant, and Jesse M. Lewin
Factors Influencing Treatment Adherence in Chronic Spontaneous Urticaria: A Systematic Review, Aditya Joshi, Lauren Gawey, Muhammad Rahman, Raveena Ghanshani, Khiem A. Tran, Adam Friedman, Jennifer L. Hsiao, and Vivian Y. Shi
Consensus Statement on the Prevention and Management of Complications of Fully Ablative Laser Resurfacing of the Face, Bianca Y. Kang, Joel L. Cohen, Roy Geronemus, Suzanne L. Kilmer, Edward Victor Ross, Elizabeth L. Tanzi, Jill S. Waibel, Brian J. Wong, Murad Alam, Macrene Alexiades, Kenneth A. Arndt, Mathew Avram, Ashish C. Bhatia, Brian Stuart Biesman, Jason D. Bloom, A Jay Burns, Henry H. Chan, Catherine M. DiGiorgio, Jeffrey S. Dover, Sam Fathizadeh, Sara C. Esteves, Michael H. Gold, Gerald N. Goldberg, Merete Haedersdal, Elika Hoss, Omar A. Ibrahimi, H Ray Jalian, Kristen M. Kelly, Woraphong Manuskiatti, Lisa A. Marks, Girish S. Munavalli, and Jason N. Pozner
The Association Between Atopic Dermatitis and Select Disease Events in Adults in the United States: A Retrospective Cohort Study in the Optum Electronic Health Records Database, Adina R. Lemeshow, Alexander Egeberg, Thomas Edwards, Stephen E. Schachterle, William Romero, Daniela E. Myers, Shefali Vyas, and Jonathan I. Silverberg
Successful treatment of recalcitrant amyopathic dermatomyositis with deucravacitinib in addition to intravenous immunoglobulin, Megan E. McNamara and Leonardo Tjahjono
What Does Long-Term Control in Atopic Dermatitis Look Like?, Shanthi Narla, Zelma C. Chiesa Fuxench, Katrina Abuabara, Lisa A. Beck, Raj Chovatiya, Diamant Thaçi, and Jonathan I. Silverberg
Current updates in the epidemiology and comorbidities of atopic dermatitis, Shanthi Narla and Jonathan I. Silverberg
The Effectiveness of an Educational Intervention to Introduce Adolescents From Marginalized Backgrounds to Dermatology: A Pilot Initiative, Heli Patel, Hrushikesh Patel, Ross O'Hagan, Robert Smith, Adam Friedman, Rishab Revankar, Pamela Allen, and Seemal R. Desai
A Review of Glucagon-like Peptide-1 in Dermatology, Willmar Patino, Amanda Thomas, Sanjana Jain, James Q. Del Rosso, and Naiem T. Issa
A Scoping Review of Pruritic Papular Eruption in People Living With HIV, Vincent Pecora, Yagiz Matthew Akiska, and Adam Friedman
Treatment of Port Wine Birthmark With Nude Tattoo Using Multiple Laser Modalities, Vincent Pecora, Emily Murphy, and Pooja Sodha
Adjuvant Cemiplimab or Placebo in High-Risk Cutaneous Squamous-Cell Carcinoma, Danny Rischin, Sandro Porceddu, Fiona Day, Daniel P. Brungs, Hayden Christie, James E. Jackson, Brian N. Stein, Yungpo Bernard Su, Rahul Ladwa, Gerard Adams, Samantha E. Bowyer, Zulfiquer Otty, Naoya Yamazaki, Paolo Bossi, Amarnath Challapalli, Axel Hauschild, Annette M. Lim, Vishal A. Patel, Joanna L. Walker, Maite De Liz Vassen Schurmann, Paola Queirolo, Javier Cañueto, Flavio Augusto Ferreira da Silva, Alexander Stratigos, Alexander Guminski, Charles Lin, Fernanda Damian, Lukas Flatz, Anne E. Taylor, David R. Carr, Samuel Harris, and Dmitry Kirtbaya
Consensus on core domains for hand eczema trials: Signs, symptoms, control and quality of life, Henriette Rönsch, Karl Philipp Drewitz, Amber Reck Atwater, Detlef Becker, Philipp Bentz, Richard Brans, Tricia Chong, Heinrich Dickel, Peter Elsner, Ana M. Giménez-Arnau, Fabrizio Guarneri, María Graciela Guzmán Perera, Sarah Ibrahim, Dimitra Koumaki, Jamie Koelbel, Francesca Larese Filon, Suzana Ljubojević Hadžavdić, Laura Loman, Mihaly Matura, Sonja Molin, Robert Ofenloch, Katharina Piontek, Radoslaw Spiewak, Anne Strunk, Margo Reeder, David Reissig, Thomas Rustemeyer, Marie-Louise Schuttelaar, Dagmar Simon, Manon Sloot, Markus F. Steiner, and Saïda Tongalaza
Switching from Dupilumab to Abrocitinib in Patients with Moderate-to-Severe Atopic Dermatitis: A Podcast Article, Vivian Y. Shi, Erman Güler, Brian Esparza, and Jonathan I. Silverberg
Burden of mild and moderate atopic dermatitis in adults: results from a real-world study in the United States, Jonathan I. Silverberg, Peter Anderson, Joseph C. Cappelleri, James Piercy, Mark E. Levenberg, Daniela E. Myers, and Robert A. Gerber
Lebrikizumab vs Other Systemic Monotherapies for Moderate-to-Severe Atopic Dermatitis: Network Meta-analysis of Efficacy, Jonathan I. Silverberg, Thomas Bieber, Amy S. Paller, Lisa Beck, Masahiro Kamata, Luis Puig, Marni Wiseman, Khaled Ezzedine, Alan D. Irvine, Peter Foley, James Del Rosso, Linda Stein Gold, Erin Johansson, Martin Dossenbach, Gaia Gallo, Buelent Akmaz, Marta Casillas, Andrei Karlsson, Tristan Curteis, and Raj Chovatiya
Lebrikizumab vs Other Systemic Monotherapies for Moderate-to-Severe Atopic Dermatitis: Network Meta-analysis of Efficacy, Jonathan I. Silverberg, Thomas Bieber, Amy S. Paller, Lisa Beck, Masahiro Kamata, Luis Puig, Marni Wiseman, Khaled Ezzedine, Alan D. Irvine, Peter Foley, James Del Rosso, Linda Stein Gold, Erin Johansson, Martin Dossenbach, Gaia Gallo, Buelent Akmaz, Marta Casillas, Andrei Karlsson, Tristan Curteis, and Raj Chovatiya
Atopic dermatitis starting in childhood has a stronger impact on adults: results from the "Scars of Life" international project in 27 countries, Jonathan I. Silverberg, Roni Dodiuk-Gad, Roberto Takaoka, Jerry Tan, Chaoying Gu, Thomas Luger, Bruno Halioua, Flavia Aslanian, Cita Rosita Prakoeswa, Ann'Laure Demessant Flavigny, Caroline Le Floc'h, Nabil Kerrouche, Stéphanie Methand, Wendy Smith Begolka, África Luca Smith, Shulamit Burstein, Delphine Kerob, Charles Taieb, Charbel Skayem, Therdpong Tempark, Abraham Getachew Kelbore, Alexander Stratigos, Martin Steinhoff, Julien Seneschal, and Laurent Misery
Orismilast, a PDE4B/D inhibitor, in moderate-to-severe atopic dermatitis: Efficacy and safety from a multicenter, randomized, placebo-controlled, phase 2b dose-ranging study (ADESOS), Jonathan I. Silverberg, Lawrence F. Eichenfield, Andrew Blauvelt, Alan D. Irvine, Emma Guttman-Yassky, Richard G. Langley, Richard B. Warren, Lars E. French, Jakob Felding, Anne Weiss, Claus B. Pedersen, Morten L. Jensen, Anna Carlsson, Morten O. Sommer, Kim Kjøller, and Eric L. Simpson
Patients' Experiences of Atopic Dermatitis and Nemolizumab Treatment: An In-Trial Interview Study Embedded in a Phase 3 Clinical Trial (ARCADIA), Jonathan I. Silverberg, Dina Filipenko, Carla Dias Barbosa, Danielle Rodriguez, Olivier Chambenoit, Katrin Jack, Christophe Piketty, Ram Subramanian, and Jorge Puelles
Achieving Optimal Treatment Targets and Minimal Disease Activity with Upadacitinib for Moderate-to-Severe Atopic Dermatitis: Integrated Analysis of Phase 3 Studies (Measure Up 1 and 2), Jonathan I. Silverberg, Melinda Gooderham, Norito Katoh, Valeria Aoki, Andrew E. Pink, Yousef Binamer, Brad Glick, Petra Staubach, Brian Calimlim, Chao Li, Ayman Grada, Alvaro Moreira, Wan-Ju Lee, and Andreas Wollenberg
Impact of Achieving Optimal Treatment Targets and Minimal Disease Activity on Health-Related Quality of Life and Satisfaction in Patients with Atopic Dermatitis, Jonathan I. Silverberg, Melinda Gooderham, Andreas Wollenberg, Andrew E. Pink, Diego Ruiz Dasilva, Shawn G. Kwatra, Yousef Binamer, Norito Katoh, Valeria Aoki, Alvaro Moreira, Ayman Grada, Chao Li, Brian Calimlim, Wan-Ju Lee, and Christopher G. Bunick
Atopic Dermatitis and Parental Guilt in the United States: Results of a Nationwide Study, Jonathan I. Silverberg, Delphine Kerob, Caroline Le Floc'h, Charles Taieb, Wendy Smith Begolka, Ann'Laure Demessant-Flavigny, and Charbel Skayem
Psychometric Validation of the Subject Sleep Diary in Patients with Moderate-to-Severe Atopic Dermatitis, Jonathan I. Silverberg, Danielle N. Rodriguez, Carla Dias-Barbosa, Dina Filipenko, Liliana Ulianov, Christophe Piketty, and Jorge Puelles
Psychometric Validation of the Subject Sleep Diary in Patients with Moderate-to-Severe Atopic Dermatitis, Jonathan I. Silverberg, Danielle N. Rodriguez, Carla Dias-Barbosa, Dina Filipenko, Liliana Ulianov, Christophe Piketty, and Jorge Puelles
Prevalence, severity and predictors of hand eczema in patients treated for atopic dermatitis: a cross-sectional observational study, Jonathan I. Silverberg, Archana Samynathan, and Jacob P. Thyssen
Switching from Dupilumab to Abrocitinib in Patients With Moderate-to-Severe Atopic Dermatitis: A Post Hoc Analysis of Efficacy After Treatment With Dupilumab in JADE DARE, Jonathan I. Silverberg, Eric L. Simpson, Andrew E. Pink, Stephan Weidinger, Gary Chan, Pinaki Biswas, Claire Clibborn, and Erman Güler
Chronic skin conditions and life trajectories: development and validation of "Dermatology Long-Term Life Impact Measure (DLLIM)", Jonathan I. Silverberg, Charbel Skayem, Ann'Laure Demessant Flavigny, Caroline Le Floc'h, Stéphanie Methand, Wendy Smith Begolka, África Luca Smith, Shulamit Burstein, Claire Della Vedova, Emmanuel Chamorey, Delphine Kerob, Charles Taieb, and Khaled Ezzedine
Long-Term Safety and Efficacy with Roflumilast Cream 0.15% in Patients Aged ≥6 Years with Atopic Dermatitis: A Phase 3 Open-Label Extension Trial, Eric L. Simpson, Lawrence F. Eichenfield, Kim A. Papp, Seth B. Forman, Adelaide A. Hebert, Mercedes E. Gonzalez, Melinda J. Gooderham, H Chih-Ho Hong, Vimal H. Prajapati, Emma Guttman-Yassky, Jonathan I. Silverberg, Melissa S. Seal, David Krupa, Erin Almaraz, Diane Hanna, Patrick Burnett, Scott Snyder, David H. Chu, Robert C. Higham, and David R. Berk
Do Allergic Comorbidities Alter the Efficacy and Safety of Abrocitinib or Dupilumab in Patients with Moderate-to-Severe Atopic Dermatitis?, Eric L. Simpson, Jonathan I. Silverberg, Bob Geng, José-Manuel Carrascosa, Thomas Bieber, Patrick M. Brunner, Delphine Staumont-Sallé, Chao Ji, Pinaki Biswas, Claire Feeney, Irene Hernández-Martín, Francisco José Rebollo Laserna, and Herwig Koppensteiner
Rapid Itch Improvement and Skin Clearance with Upadacitinib Versus Placebo (Measure Up 1 and Measure Up 2) and Versus Dupilumab (Heads Up): Results from Three Phase 3 Clinical Trials in Patients with Moderate-to-Severe Atopic Dermatitis, Eric L. Simpson, Jonathan I. Silverberg, Vimal H. Prajapati, Kilian Eyerich, Norito Katoh, Mark Boguniewicz, Emma Guttman-Yassky, E James Song, Wan-Ju Lee, Henrique D. Teixeira, Tianshuang Wu, Cristina Sancho Sanchez, Namita Vigna, Brian M. Calimlim, and Marjolein de Bruin-Weller
Enhanced metastatic risk stratification for Cutaneous Squamous Cell Carcinoma by combining clinical guidelines with the Erasmus MC model: Results from Two Nationwide Nested Case-Control Studies, O F. Steijlen, L Pozza, J J. Traets, B Rentroia-Pacheco, C J. Eggermont, D Bellomo, S Alex, V A. Patel, A L. Mooyaart, L M. Hollestein, and M Wakkee
Response to [Zheng et al.,] "Letter to "Enhanced metastatic risk stratification for Cutaneous Squamous Cell Carcinoma by combining clinical guidelines with the Erasmus MC model".", Olivia F. Steijlen, Lara Pozza, Joleen J. Traets, Barbara Rentroia-Pacheco, Celeste J. Eggermont, Domenico Bellomo, Sheril Alex, Vishal A. Patel, Antien L. Mooyaart, Loes M. Hollestein, and Marlies Wakkee
Acral Lentiginous Melanoma. Part I. Epidemiology, Etiology, Clinical Presentation, and Diagnosis, Sach Thakker, Daniella Jaguan, Micah Belzberg, Nina Gulati, Janeth R. Campbell, Brittney K. DeClerck, Gino K. In, and Vishal A. Patel
An Ethical Framework for Managing Neglected Skin Tumors in Older Patients, Sach Thakker, Kira Minkis, Shari R. Lipner, Nicholas Gulati, Vishal A. Patel, and Jafar Al-Mondhiry
Prevalence and Characteristics of Chronic Hand Eczema Among Adults in Denmark: A General Population-Based Study, David Thein, Julia-Tatjana Maul, Simone Ribero, Jonathan I. Silverberg, Alexander Egeberg, and Jacob P. Thyssen
Lichen Planus: A Cross-Sectional Evaluation of US Dermatologists' Comorbidity Screening and Management Patterns, Savanna I. Vidal, Nikita Menta, and Adam Friedman
Child and Adult Seborrheic Dermatitis: A Narrative Review of the Current Treatment Landscape, Savanna I. Vidal, Nikita Menta, and Lawrence Green
Child and Adult Seborrheic Dermatitis: A Narrative Review of the Current Treatment Landscape, Savanna I. Vidal, Nikita Menta, and Lawrence Green
Rademikibart monotherapy for moderate-to-severe atopic dermatitis in a 1-year, randomized, phase II trial (SEASIDE CHINA): initial two-week dosing, followed by two-week or four-week dosing, Jianzhong Zhang, Jonathan I. Silverberg, Jiawang Guo, Jili Yun, Wuban Pan, Zheng Wei, and Raúl Collazo
Submissions from 2024
Applications of nitric oxide-releasing nanomaterials in dermatology: Skin infections and wound healing, Sara Abdel Azim, Cleo Whiting, and Adam J. Friedman
Tyrosine Kinase 2 Inhibition With Zasocitinib (TAK-279) in Psoriasis: A Randomized Clinical Trial, April W. Armstrong, Melinda Gooderham, Charles Lynde, Catherine Maari, Seth Forman, Lawrence Green, Vivian Laquer, Xinyan Zhang, Nathalie Franchimont, Esha A. Gangolli, Jessamyn Blau, Yiwei Zhao, Wenwen Zhang, Bhaskar Srivastava, Graham Heap, and Kim Papp
Tyrosine Kinase 2 Inhibition With Zasocitinib (TAK-279) in Psoriasis: A Randomized Clinical Trial, April W. Armstrong, Melinda Gooderham, Charles Lynde, Catherine Maari, Seth Forman, Lawrence Green, Vivian Laquer, Xinyan Zhang, Nathalie Franchimont, Esha A. Gangolli, Jessamyn Blau, Yiwei Zhao, Wenwen Zhang, Bhaskar Srivastava, Graham Heap, and Kim Papp
Efficacy of Upadacitinib and Dupilumab on Achieving Stringent and Composite Skin and Itch Outcomes: an Indirect Comparison of Adults with Moderate-to-Severe Atopic Dermatitis, April W. Armstrong, H Chih-Ho Hong, Brian M. Calimlim, Marric G. Buessing, Marjorie M. Crowell, and Jonathan I. Silverberg
Efficacy of Upadacitinib and Dupilumab on Achieving Stringent and Composite Skin and Itch Outcomes: an Indirect Comparison of Adults with Moderate-to-Severe Atopic Dermatitis, April W. Armstrong, H Chih-Ho Hong, Brian M. Calimlim, Marric G. Buessing, Marjorie M. Crowell, and Jonathan I. Silverberg
Evaluating the Readability of the iPledge Comprehension Assessment and its Impact on Isotretinoin Accessibility, Peter Baek, Nidhi Shah, and A Yasmine Kirkorian
Roflumilast foam 0.3% for adolescent and adult patients with seborrheic dermatitis: A randomized, double-blinded, vehicle-controlled, phase 3 trial, Andrew Blauvelt, Zoe D. Draelos, Linda Stein Gold, Javier Alonso-Llamazares, Neal Bhatia, Janet DuBois, Seth B. Forman, Melinda Gooderham, Lawrence Green, Scott T. Guenthner, Adelaide A. Hebert, Edward Lain, Angela Y. Moore, Kim A. Papp, Matthew Zirwas, Saori Kato, Scott Snyder, David Krupa, Patrick Burnett, David R. Berk, and David H. Chu
More Time Spent with Clear Skin and No Itch with Upadacitinib versus Dupilumab for Atopic Dermatitis, Andrew Blauvelt, Kilian Eyerich, Alan D. Irvine, Marjolein de Bruin-Weller, Shawn G. Kwatra, Melinda Gooderham, Brian Kim, Brian M. Calimlim, Wan-Ju Lee, Eliza M. Raymundo, Yingyi Liu, Sarah Ofori, Andrew M. Platt, and Jonathan I. Silverberg
More Time Spent with Clear Skin and No Itch with Upadacitinib versus Dupilumab for Atopic Dermatitis, Andrew Blauvelt, Kilian Eyerich, Alan D. Irvine, Marjolein de Bruin-Weller, Shawn G. Kwatra, Melinda Gooderham, Brian Kim, Brian M. Calimlim, Wan-Ju Lee, Eliza M. Raymundo, Yingyi Liu, Sarah Ofori, Andrew M. Platt, and Jonathan I. Silverberg
Cendakimab in Patients With Moderate to Severe Atopic Dermatitis: A Randomized Clinical Trial, Andrew Blauvelt, Emma Guttman-Yassky, Charles Lynde, Saakshi Khattri, Joel Schlessinger, Shinichi Imafuku, Yayoi Tada, Akimichi Morita, Marni Wiseman, Bartlomiej Kwiek, Martina Machkova, Peijin Zhang, Misti Linaberry, Jie Li, Sandra Zhang, Giovanni Franchin, Edgar D. Charles, Claudia H. De Oliveira, and Jonathan I. Silverberg
Cendakimab in Patients With Moderate to Severe Atopic Dermatitis: A Randomized Clinical Trial, Andrew Blauvelt, Emma Guttman-Yassky, Charles Lynde, Saakshi Khattri, Joel Schlessinger, Shinichi Imafuku, Yayoi Tada, Akimichi Morita, Marni Wiseman, Bartlomiej Kwiek, Martina Machkova, Peijin Zhang, Misti Linaberry, Jie Li, Sandra Zhang, Giovanni Franchin, Edgar D. Charles, Claudia H. De Oliveira, and Jonathan I. Silverberg
Executive summary: Consensus treatment guidelines for the use of methotrexate for inflammatory skin disease in pediatric patients, Heather A. Brandling-Bennett, Lisa M. Arkin, Yvonne E. Chiu, Adelaide A. Hebert, Jeffrey P. Callen, Leslie Castelo-Soccio, Dominic O. Co, Kelly M. Cordoro, Megan L. Curran, Austin M. Dalrymple, Carsten Flohr, Ken B. Gordon, Diane Hanna, Alan D. Irvine, Susan Kim, A Yasmine Kirkorian, Irene Lara-Corrales, Jill Lindstrom, Amy S. Paller, Melissa Reyes, Wendy Smith Begolka, Wynnis L. Tom, Abby S. Van Voorhees, Ruth Ann Vleugels, Lara Wine Lee, Olivia Davies, and Elaine C. Siegfried
Association of alopecia areata and ischemic heart disease and cerebrovascular in U.S. adults: an all of us database study, Stella Caldas, Angel D. Pagan, Juliana Pulsinelli, Joel Correa da Rosa, Seungyeon Jung, Divija Sharma, Jonas A. Adalsteinsson, and Benjamin Ungar
Pediatric Cutaneous T-Cell Neoplasms: Clinical and Pathological Features, Updated Classifications, and Critical Differential Diagnoses, Jinjun Cheng, Birte Wistinghausen, and A Yasmine Kirkorian
Attitudes, practices, facilitators, and barriers to sexual orientation and gender identity data collection in dermatology practices, Richard Chen, Temi Adekunle, Lena Chu, Ronnie Festok, Julia L. Gao, Daniel A. Yanes, Erica D. Dommasch, John G. Zampella, and Howa Yeung
Standardizing Retrospective Observational Research in Cutaneous Squamous Cell Carcinoma: Expert Panel Guidelines from ITSCC, Shayan Cheraghlou, Mary L. Stevenson, Sean R. Christensen, Jeremy S. Bordeaux, Joanna L. Walker, Divya Srivastava, Carla Ferrándiz-Pulido, Kristin P. Bibee, Joi B. Carter, Faramarz H. Samie, Vishal A. Patel, Bryan T. Carroll, Allison T. Vidimos, Christian L. Baum, Justin J. Leitenberger, Anokhi Jambusaria-Pahlajani, Emily S. Ruiz, John A. Carucci, David R. Carr, and Kathryn T. Shahwan
Standardizing Retrospective Observational Research in Cutaneous Squamous Cell Carcinoma: Expert Panel Guidelines from ITSCC, Shayan Cheraghlou, Mary L. Stevenson, Sean R. Christensen, Jeremy S. Bordeaux, Joanna L. Walker, Divya Srivastava, Carla Ferrándiz-Pulido, Kristin P. Bibee, Joi B. Carter, Faramarz H. Samie, Vishal A. Patel, Bryan T. Carroll, Allison T. Vidimos, Christian L. Baum, Justin J. Leitenberger, Anokhi Jambusaria-Pahlajani, Emily S. Ruiz, John A. Carucci, David R. Carr, and Kathryn T. Shahwan
Atopic dermatitis (eczema) guidelines: 2023 American Academy of Allergy, Asthma and Immunology/American College of Allergy, Asthma and Immunology Joint Task Force on Practice Parameters GRADE- and Institute of Medicine-based recommendations, Derek K. Chu, Lynda Schneider, Rachel Netahe Asiniwasis, Mark Boguniewicz, Anna De Benedetto, Kathy Ellison, Winfred T. Frazier, Matthew Greenhawt, Joey Huynh, Elaine Kim, Jennifer LeBovidge, Mary Laura Lind, Peter Lio, Stephen A. Martin, Monica O'Brien, Peck Y. Ong, Jonathan I. Silverberg, Jonathan M. Spergel, Julie Wang, Kathryn E. Wheeler, and Gordon H. Guyatt
Photopatch testing: Clinical characteristics, test results, and final diagnoses from the North American Contact Dermatitis Group, 2009-2020, Vincent A. DeLeo, Brandon L. Adler, Donald V. Belsito, Melanie D. Pratt, Denis Sasseville, Margo J. Reeder, Erin M. Warshaw, Amber R. Atwater, James S. Taylor, Frances Storrs, James G. Marks, Joel G. DeKoven, Jonathan Silverberg, JiaDe Yu, Nina Botto, Marie-Claude Houle, Christen M. Mowad, and Cory A. Dunnick
Isotretinoin for rosacea: A systematic review, Sapana Desai and Adam Friedman
Capturing patient-reported sleep disturbance in atopic dermatitis clinical trials, Carla Dias-Barbosa, Jonathan I. Silverberg, Sonja Ständer, Danielle Rodriguez, Fatoumata Fofana, Dina Filipenko, Liliana Ulianov, Christophe Piketty, and Jorge Puelles
Biologics and oral systemic treatment preferences in patients and physicians for moderate-to-severe atopic dermatitis: a discrete choice experiment in the United Kingdom and Germany, Nicholas Durno, Pablo Arija, Krystallia Pantiri, Marieke Heisen, Marco Boeri, Josef Paris, Katrin Jack, Olivier Chambenoit, Ramkumar Subramanian, Jorge Puelles, Elly Stolk, Ben van Hout, and Jonathan I. Silverberg
Biologics and oral systemic treatment preferences in patients and physicians for moderate-to-severe atopic dermatitis: a discrete choice experiment in the United Kingdom and Germany, Nicholas Durno, Pablo Arija, Krystallia Pantiri, Marieke Heisen, Marco Boeri, Josef Paris, Katrin Jack, Olivier Chambenoit, Ramkumar Subramanian, Jorge Puelles, Elly Stolk, Ben van Hout, and Jonathan I. Silverberg
Targeting the aryl hydrocarbon receptor as a strategy to expand the therapeutic armamentarium in atopic dermatitis, Lawrence F. Eichenfield, Jonathan I. Silverberg, Adelaide A. Hebert, and Mark Boguniewicz
Efficacy, Safety, and Long-Term Disease Control of Ruxolitinib Cream Among Adolescents with Atopic Dermatitis: Pooled Results from Two Randomized Phase 3 Studies, Lawrence F. Eichenfield, Eric L. Simpson, Kim Papp, Jacek C. Szepietowski, Andrew Blauvelt, Leon Kircik, Jonathan I. Silverberg, Elaine C. Siegfried, Michael E. Kuligowski, May E. Venturanza, Howard Kallender, Haobo Ren, and Amy S. Paller
Rx -to- OTC switch increased access and lowered cost of topical adapalene, William Fix, Sapana Desai, Dillon Nussbaum, and Adam Friedman
A Practical Approach to Diagnosing and Managing Chronic Spontaneous Urticaria, Adam Friedman, Shawn G. Kwatra, and Gil Yosipovitch
A Practical Approach to Diagnosing and Managing Chronic Spontaneous Urticaria, Adam Friedman, Shawn G. Kwatra, and Gil Yosipovitch